The shifting therapeutic paradigm for relapsed/refractory mantle cell lymphoma
Sumukh Arun Kumar, Jenny Gao, Shyam A. Patel
Topics & Concepts
IbrutinibMedicineMantle cell lymphomaTolerabilityOncologyInternal medicineBrentuximab vedotinChimeric antigen receptorTargeted therapyPopulationLymphomaClinical trialAdverse effectHodgkin lymphomaImmunotherapyLeukemiaChronic lymphocytic leukemiaCancerEnvironmental healthLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCAR-T cell therapy research